Evidence map›Paper›PMID 40490306›Full record

ArticleJournal of proteome research2025

Children with Post COVID-19 Multisystem Inflammatory Syndrome Display Unique Pathophysiological Metabolic Phenotypes.

Nathan G Lawler, Lael M Yonker, Samantha Lodge, Philipp Nitschke, Maureen M Leonard, Nicola Gray, Luke Whiley, Reika Masuda, Elaine Holmes, Julien Wist and 2 more

Abstract read
In one paragraph

Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nathan G LawlerAustralian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.ORCID 0000-0001-9649-425X
Lael M YonkerDepartment of Pediatrics, Massachusetts General Hospital, Mucosal Immunology and Biology Research Center, Boston, Massachusetts 02114, United States.
Samantha LodgeAustralian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.ORCID 0000-0001-9193-0462
Philipp NitschkeAustralian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.ORCID 0000-0002-5814-7529
Maureen M LeonardDepartment of Pediatrics, Massachusetts General Hospital, Mucosal Immunology and Biology Research Center, Boston, Massachusetts 02114, United States.
Nicola GrayAustralian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.ORCID 0000-0002-0094-5245
Luke WhileyAustralian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.ORCID 0000-0002-9088-4799
Reika MasudaAustralian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.
Elaine HolmesAustralian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.ORCID 0000-0002-0556-8389
Julien WistAustralian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.ORCID 0000-0002-3416-2572
Alessio FasanoDepartment of Pediatrics, Massachusetts General Hospital, Mucosal Immunology and Biology Research Center, Boston, Massachusetts 02114, United States.
Jeremy K NicholsonAustralian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.ORCID 0000-0002-8123-8349

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Takara Leah Stanley · 1994 to 2026
$31.6M
Microbiome-derived Metabolites Linked to Celiac Disease Onset in Infants at RiskR01DK104344 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FASANO, ALESSIO · 2016 to 2020
$3.4M
Defining neutrophil pathobiology in pediatric Long COVIDR01HL173059 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI Lael Yonker · 2024 to 2026
$2.4M
The Celiac Disease Genomic, Environmental, Microbiome, and Metabolomic (CD-GEMM) Prospective Cohort StudyR56AI169645 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI FASANO, ALESSIO · 2023 to 2023
$823k
NHLBI NIH HHS R01 HL173059NIAID NIH HHS R56 AI169645NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R01 DK104344
6 · The paper itself

Abstract

SARS-CoV-2 infections in children lead to symptoms from mild respiratory illness to severe postacute sequelae of COVID-19, including multisystem inflammatory syndrome in Children (MIS-C). We conducted a metabolic profiling of 147 children's serum samples, including acute COVID-19 patients, MIS-C patients, and healthy controls. Using nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry, we measured 1101 metabolites. The results revealed distinct metabolic profiles in acute COVID-19 and MIS-C patients, with significant alterations in lipid classes. Both conditions exhibited an elevated Apo-B100/Apo-A1 ratio and increased serum inflammatory markers. MIS-C patients showed unique disruptions, including increased triglycerides and altered lipoprotein composition. Despite milder clinical respiratory symptoms, children's metabolic disturbances mirrored those seen in severe adult COVID-19 patients, indicating a shared inflammatory response to SARS-CoV-2. This suggests potential long-term health impacts, underscoring the need for continued research into the metabolic consequences of COVID-19 in children.

Indexed as

COVID-19MetabolomeSystemic Inflammatory Response SyndromeAdolescentBiomarkersCase-Control StudiesChildChild, PreschoolFemaleHumansMagnetic Resonance SpectroscopyMaleMetabolomicsPhenotypeSARS-CoV-2Biomarkershyper-inflammationinflammationlipidslipoproteinsmass spectrometrynuclear magnetic resonance spectroscopyphenoconversionSARS-CoV-2

Identifiers

PMID40490306
PMCPMC12235697

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.